Cargando…

Exploring Barriers to Medication Adherence Using COM-B Model of Behaviour Among Patients with Cardiovascular Diseases in Low- and Middle-Income Countries: A Qualitative Study

INTRODUCTION: In 2016, cardiovascular diseases (CVDs) led to 17.9 million deaths worldwide, representing 31% of all global deaths. CVDs are the leading cause of mortality worldwide and significant barriers to achieving the sustainable development goals. Modern medicines have been significant in impr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Pallavi, Vamadevan, Ajay S, Roy, Ambuj, Bhatia, Rohit, Naik, Nitish, Singh, Sandeep, Amevinya, Gideon Senyo, Ampah, Ernest Amoah, Fernandez, Yolanda, Free, Caroline, Laar, Amos, Prabhakaran, Dorairaj, Perel, Pablo, Legido-Quigley, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236251/
https://www.ncbi.nlm.nih.gov/pubmed/34188453
http://dx.doi.org/10.2147/PPA.S285442
_version_ 1783714500476665856
author Mishra, Pallavi
Vamadevan, Ajay S
Roy, Ambuj
Bhatia, Rohit
Naik, Nitish
Singh, Sandeep
Amevinya, Gideon Senyo
Ampah, Ernest Amoah
Fernandez, Yolanda
Free, Caroline
Laar, Amos
Prabhakaran, Dorairaj
Perel, Pablo
Legido-Quigley, Helena
author_facet Mishra, Pallavi
Vamadevan, Ajay S
Roy, Ambuj
Bhatia, Rohit
Naik, Nitish
Singh, Sandeep
Amevinya, Gideon Senyo
Ampah, Ernest Amoah
Fernandez, Yolanda
Free, Caroline
Laar, Amos
Prabhakaran, Dorairaj
Perel, Pablo
Legido-Quigley, Helena
author_sort Mishra, Pallavi
collection PubMed
description INTRODUCTION: In 2016, cardiovascular diseases (CVDs) led to 17.9 million deaths worldwide, representing 31% of all global deaths. CVDs are the leading cause of mortality worldwide and significant barriers to achieving the sustainable development goals. Modern medicines have been significant in improving health outcomes. However, non-adherence to medication is one of the reasons behind adverse health-related outcomes among patients suffering from atherosclerotic cardiovascular disease in low- and middle-income countries. PATIENTS AND METHODS: This qualitative study was conducted at two tertiary care hospitals in India and Ghana. A total of 35 in-depth interviews were conducted with atherosclerosis cardiovascular disease (ASCVD) patients. The data were analysed thematically using the Capability Opportunity and Motivation (COM-B) framework. FINDINGS: The findings were summarised under three important broad themes of the COM-B framework: capability, opportunity and behaviour. Under capability, comprehension of disease, medication schedule, and unplanned travel affected adherence among patients. Cost of medication, insurance and access were the critical factors under opportunity, which negatively influenced medication adherence. Mood, beliefs about treatment and outcome expectations under motivation led to non-adherence among patients. Apart from these factors, some important health system factors such as health care experience and trust in the facilities and reliance on alternative medication also affected adherence in both countries. CONCLUSION: This study has highlighted that the health system factors have dominantly influenced adherence to medication in India and Ghana. In India, we found participants to be satisfied with their health care provided at the government hospitals. However, limited time for consultation, lack of well-stocked pharmacy and unclear prescription negatively influenced adherence among participants in India and Ghana. The study emphasises that the health system needs to be strengthened, and the patients’ belief system needs to be explored to address the issue of medication adherence in LMICs.
format Online
Article
Text
id pubmed-8236251
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-82362512021-06-28 Exploring Barriers to Medication Adherence Using COM-B Model of Behaviour Among Patients with Cardiovascular Diseases in Low- and Middle-Income Countries: A Qualitative Study Mishra, Pallavi Vamadevan, Ajay S Roy, Ambuj Bhatia, Rohit Naik, Nitish Singh, Sandeep Amevinya, Gideon Senyo Ampah, Ernest Amoah Fernandez, Yolanda Free, Caroline Laar, Amos Prabhakaran, Dorairaj Perel, Pablo Legido-Quigley, Helena Patient Prefer Adherence Original Research INTRODUCTION: In 2016, cardiovascular diseases (CVDs) led to 17.9 million deaths worldwide, representing 31% of all global deaths. CVDs are the leading cause of mortality worldwide and significant barriers to achieving the sustainable development goals. Modern medicines have been significant in improving health outcomes. However, non-adherence to medication is one of the reasons behind adverse health-related outcomes among patients suffering from atherosclerotic cardiovascular disease in low- and middle-income countries. PATIENTS AND METHODS: This qualitative study was conducted at two tertiary care hospitals in India and Ghana. A total of 35 in-depth interviews were conducted with atherosclerosis cardiovascular disease (ASCVD) patients. The data were analysed thematically using the Capability Opportunity and Motivation (COM-B) framework. FINDINGS: The findings were summarised under three important broad themes of the COM-B framework: capability, opportunity and behaviour. Under capability, comprehension of disease, medication schedule, and unplanned travel affected adherence among patients. Cost of medication, insurance and access were the critical factors under opportunity, which negatively influenced medication adherence. Mood, beliefs about treatment and outcome expectations under motivation led to non-adherence among patients. Apart from these factors, some important health system factors such as health care experience and trust in the facilities and reliance on alternative medication also affected adherence in both countries. CONCLUSION: This study has highlighted that the health system factors have dominantly influenced adherence to medication in India and Ghana. In India, we found participants to be satisfied with their health care provided at the government hospitals. However, limited time for consultation, lack of well-stocked pharmacy and unclear prescription negatively influenced adherence among participants in India and Ghana. The study emphasises that the health system needs to be strengthened, and the patients’ belief system needs to be explored to address the issue of medication adherence in LMICs. Dove 2021-06-23 /pmc/articles/PMC8236251/ /pubmed/34188453 http://dx.doi.org/10.2147/PPA.S285442 Text en © 2021 Mishra et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Mishra, Pallavi
Vamadevan, Ajay S
Roy, Ambuj
Bhatia, Rohit
Naik, Nitish
Singh, Sandeep
Amevinya, Gideon Senyo
Ampah, Ernest Amoah
Fernandez, Yolanda
Free, Caroline
Laar, Amos
Prabhakaran, Dorairaj
Perel, Pablo
Legido-Quigley, Helena
Exploring Barriers to Medication Adherence Using COM-B Model of Behaviour Among Patients with Cardiovascular Diseases in Low- and Middle-Income Countries: A Qualitative Study
title Exploring Barriers to Medication Adherence Using COM-B Model of Behaviour Among Patients with Cardiovascular Diseases in Low- and Middle-Income Countries: A Qualitative Study
title_full Exploring Barriers to Medication Adherence Using COM-B Model of Behaviour Among Patients with Cardiovascular Diseases in Low- and Middle-Income Countries: A Qualitative Study
title_fullStr Exploring Barriers to Medication Adherence Using COM-B Model of Behaviour Among Patients with Cardiovascular Diseases in Low- and Middle-Income Countries: A Qualitative Study
title_full_unstemmed Exploring Barriers to Medication Adherence Using COM-B Model of Behaviour Among Patients with Cardiovascular Diseases in Low- and Middle-Income Countries: A Qualitative Study
title_short Exploring Barriers to Medication Adherence Using COM-B Model of Behaviour Among Patients with Cardiovascular Diseases in Low- and Middle-Income Countries: A Qualitative Study
title_sort exploring barriers to medication adherence using com-b model of behaviour among patients with cardiovascular diseases in low- and middle-income countries: a qualitative study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236251/
https://www.ncbi.nlm.nih.gov/pubmed/34188453
http://dx.doi.org/10.2147/PPA.S285442
work_keys_str_mv AT mishrapallavi exploringbarrierstomedicationadherenceusingcombmodelofbehaviouramongpatientswithcardiovasculardiseasesinlowandmiddleincomecountriesaqualitativestudy
AT vamadevanajays exploringbarrierstomedicationadherenceusingcombmodelofbehaviouramongpatientswithcardiovasculardiseasesinlowandmiddleincomecountriesaqualitativestudy
AT royambuj exploringbarrierstomedicationadherenceusingcombmodelofbehaviouramongpatientswithcardiovasculardiseasesinlowandmiddleincomecountriesaqualitativestudy
AT bhatiarohit exploringbarrierstomedicationadherenceusingcombmodelofbehaviouramongpatientswithcardiovasculardiseasesinlowandmiddleincomecountriesaqualitativestudy
AT naiknitish exploringbarrierstomedicationadherenceusingcombmodelofbehaviouramongpatientswithcardiovasculardiseasesinlowandmiddleincomecountriesaqualitativestudy
AT singhsandeep exploringbarrierstomedicationadherenceusingcombmodelofbehaviouramongpatientswithcardiovasculardiseasesinlowandmiddleincomecountriesaqualitativestudy
AT amevinyagideonsenyo exploringbarrierstomedicationadherenceusingcombmodelofbehaviouramongpatientswithcardiovasculardiseasesinlowandmiddleincomecountriesaqualitativestudy
AT ampahernestamoah exploringbarrierstomedicationadherenceusingcombmodelofbehaviouramongpatientswithcardiovasculardiseasesinlowandmiddleincomecountriesaqualitativestudy
AT fernandezyolanda exploringbarrierstomedicationadherenceusingcombmodelofbehaviouramongpatientswithcardiovasculardiseasesinlowandmiddleincomecountriesaqualitativestudy
AT freecaroline exploringbarrierstomedicationadherenceusingcombmodelofbehaviouramongpatientswithcardiovasculardiseasesinlowandmiddleincomecountriesaqualitativestudy
AT laaramos exploringbarrierstomedicationadherenceusingcombmodelofbehaviouramongpatientswithcardiovasculardiseasesinlowandmiddleincomecountriesaqualitativestudy
AT prabhakarandorairaj exploringbarrierstomedicationadherenceusingcombmodelofbehaviouramongpatientswithcardiovasculardiseasesinlowandmiddleincomecountriesaqualitativestudy
AT perelpablo exploringbarrierstomedicationadherenceusingcombmodelofbehaviouramongpatientswithcardiovasculardiseasesinlowandmiddleincomecountriesaqualitativestudy
AT legidoquigleyhelena exploringbarrierstomedicationadherenceusingcombmodelofbehaviouramongpatientswithcardiovasculardiseasesinlowandmiddleincomecountriesaqualitativestudy